AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 99 filers reported holding AVROBIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $28,000 | -84.2% | 20,842 | -54.7% | 0.00% | – |
| Q4 2021 | $177,000 | -16.9% | 46,007 | +20.4% | 0.00% | – |
| Q3 2021 | $213,000 | -52.2% | 38,212 | -23.9% | 0.00% | – |
| Q2 2021 | $446,000 | -34.9% | 50,202 | -6.9% | 0.00% | – |
| Q1 2021 | $685,000 | +6.2% | 53,949 | +16.7% | 0.00% | – |
| Q4 2020 | $645,000 | -61.6% | 46,246 | -64.2% | 0.00% | -100.0% |
| Q3 2020 | $1,681,000 | -48.7% | 129,137 | -31.3% | 0.00% | 0.0% |
| Q2 2020 | $3,278,000 | +34.5% | 187,874 | +20.0% | 0.00% | 0.0% |
| Q1 2020 | $2,437,000 | +30.2% | 156,531 | +68.3% | 0.00% | 0.0% |
| Q4 2019 | $1,872,000 | +85.7% | 92,985 | +30.2% | 0.00% | – |
| Q3 2019 | $1,008,000 | -8.2% | 71,417 | +5.7% | 0.00% | – |
| Q2 2019 | $1,098,000 | -5.6% | 67,547 | +28.1% | 0.00% | – |
| Q1 2019 | $1,163,000 | – | 52,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |